Massimo Mannelli

58.6k total citations · 3 hit papers
215 papers, 9.0k citations indexed

About

Massimo Mannelli is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Massimo Mannelli has authored 215 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 133 papers in Surgery, 118 papers in Endocrinology, Diabetes and Metabolism and 94 papers in Cancer Research. Recurrent topics in Massimo Mannelli's work include Adrenal and Paraganglionic Tumors (123 papers), Cancer, Hypoxia, and Metabolism (91 papers) and Hormonal Regulation and Hypertension (62 papers). Massimo Mannelli is often cited by papers focused on Adrenal and Paraganglionic Tumors (123 papers), Cancer, Hypoxia, and Metabolism (91 papers) and Hormonal Regulation and Hypertension (62 papers). Massimo Mannelli collaborates with scholars based in Italy, Germany and United States. Massimo Mannelli's co-authors include Graeme Eisenhofer, Jacques W.M. Lenders, Karel Pacák, Karel Pacák, W. Marston Linehan, David S. Goldstein, Stefan R. Bornstein, McClellan M. Walther, Peter Friberg and Anne‐Paule Gimenez‐Roqueplo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Massimo Mannelli

209 papers receiving 8.7k citations

Hit Papers

Phaeochromocytoma 2002 2026 2010 2018 2005 2002 2020 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimo Mannelli Italy 46 6.4k 5.8k 4.0k 1.2k 868 215 9.0k
Laurence Amar France 48 5.5k 0.9× 5.2k 0.9× 3.1k 0.8× 1.8k 1.5× 824 0.9× 184 8.3k
Henri Timmers Netherlands 45 4.5k 0.7× 3.8k 0.7× 2.9k 0.7× 592 0.5× 607 0.7× 151 6.4k
Massimo Terzolo Italy 55 9.0k 1.4× 8.5k 1.5× 4.9k 1.2× 732 0.6× 331 0.4× 257 12.0k
Olivier Chabre France 41 2.3k 0.4× 3.2k 0.5× 1.1k 0.3× 1.0k 0.8× 231 0.3× 135 5.1k
Ettore C. degli Uberti Italy 46 1.6k 0.2× 3.9k 0.7× 880 0.2× 1.5k 1.2× 527 0.6× 224 7.0k
Giorgio Arnaldi Italy 41 2.7k 0.4× 4.5k 0.8× 675 0.2× 676 0.6× 266 0.3× 160 5.9k
Cristina L. Ronchi Italy 37 1.9k 0.3× 2.2k 0.4× 1.3k 0.3× 879 0.7× 254 0.3× 153 4.5k
Holger S. Willenberg Germany 29 2.0k 0.3× 2.5k 0.4× 893 0.2× 465 0.4× 334 0.4× 105 3.7k
Pascale de Lonlay France 49 1.2k 0.2× 1.8k 0.3× 362 0.1× 5.2k 4.3× 341 0.4× 224 8.7k
Mara Lorenzi United States 44 1.3k 0.2× 2.0k 0.3× 465 0.1× 2.8k 2.3× 477 0.5× 102 7.7k

Countries citing papers authored by Massimo Mannelli

Since Specialization
Citations

This map shows the geographic impact of Massimo Mannelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Mannelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Mannelli more than expected).

Fields of papers citing papers by Massimo Mannelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Mannelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Mannelli. The network helps show where Massimo Mannelli may publish in the future.

Co-authorship network of co-authors of Massimo Mannelli

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Mannelli. A scholar is included among the top collaborators of Massimo Mannelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Mannelli. Massimo Mannelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cioppi, Francesca, Giulia Cantini, Tonino Ercolino, et al.. (2024). Targeted Next Generation Sequencing molecular profiling and its clinical application in adrenocortical cancer. European Journal of Endocrinology. 191(1). 17–30. 2 indexed citations
2.
Cantini, Giulia, Alessio Nocentini, Letizia Canu, et al.. (2023). Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment. Journal of Endocrinological Investigation. 46(7). 1449–1458. 4 indexed citations
3.
Provenzano, Aldesia, Massimiliano Chetta, Giulia Cantini, et al.. (2022). Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia. Medicina. 58(8). 1113–1113. 4 indexed citations
4.
Cantini, Giulia, Letizia Canu, Elena Lazzeri, et al.. (2021). Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression. Journal of Personalized Medicine. 11(11). 1097–1097. 10 indexed citations
5.
Lenders, Jacques W.M., Michiel N. Kerstens, Laurence Amar, et al.. (2020). Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. Journal of Hypertension. 38(8). 1443–1456. 211 indexed citations breakdown →
6.
Contini, Elisa, Andrea Valeri, Massimiliano Chetta, et al.. (2020). Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma. International Journal of Endocrinology. 2020. 1–8. 2 indexed citations
7.
Cantini, Giulia, Letizia Canu, Roberta Armignacco, et al.. (2020). Prognostic and Monitoring Value of Circulating Tumor Cells in Adrenocortical Carcinoma: A Preliminary Monocentric Study. Cancers. 12(11). 3176–3176. 11 indexed citations
8.
Rapizzi, Elena, Stefania Benvenuti, Cristiana Deledda, et al.. (2020). A unique neuroendocrine cell model derived from the human foetal neural crest. Journal of Endocrinological Investigation. 43(9). 1259–1269. 3 indexed citations
9.
Armignacco, Roberta, Giulia Cantini, G Poli, et al.. (2019). The Adipose Stem Cell as a Novel Metabolic Actor in Adrenocortical Carcinoma Progression: Evidence from an In Vitro Tumor Microenvironment Crosstalk Model. Cancers. 11(12). 1931–1931. 18 indexed citations
10.
Poli, G, Carmen Ruggiero, Giulia Cantini, et al.. (2018). Fascin-1 Is a Novel Prognostic Biomarker Associated With Tumor Invasiveness in Adrenocortical Carcinoma. The Journal of Clinical Endocrinology & Metabolism. 104(5). 1712–1724. 33 indexed citations
11.
Armignacco, Roberta, Giulia Cantini, Letizia Canu, et al.. (2017). Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis. Journal of Endocrinological Investigation. 41(5). 499–507. 16 indexed citations
12.
Perge, Pál, Henriett Butz, Raffaele Pezzani, et al.. (2017). Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors. Scientific Reports. 7(1). 5474–5474. 51 indexed citations
13.
Leone, Alessandra, et al.. (2013). Dall’ipertensione alla pillola RU-486: un complesso caso di ipertensione secondaria. Giornale italiano di cardiologia. 14(6). 477–80.
14.
Abraham, William T., Guy Decaux, Richard C. Josiassen, et al.. (2012). Oral lixivaptan effectively increases serum sodium concentrations in outpatients with euvolemic hyponatremia. Kidney International. 82(11). 1215–1222. 28 indexed citations
15.
Luconi, Michaela, G Poli, Maria Luisa Mangoni, et al.. (2011). Effects and kinetics of mitotane in in vitro and in vivo models of adrenocortical carcinoma. Endocrine Abstracts. 26. 1 indexed citations
16.
Timmers, Henri, Anne‐Paule Gimenez‐Roqueplo, Massimo Mannelli, & Karel Pacák. (2009). Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Endocrine Related Cancer. 16(2). 391–400. 101 indexed citations
17.
Lenders, Jacques W.M., Karel Pacák, Thanh‐Truc Huynh, et al.. (2009). Low Sensitivity of Glucagon Provocative Testing for Diagnosis of Pheochromocytoma. The Journal of Clinical Endocrinology & Metabolism. 95(1). 238–245. 20 indexed citations
18.
Rossi, Gian Paolo, G Bernini, Bruno Fabris, et al.. (2005). Primary aldosteronism (PA) prevalence in Italy (papy) study: Results of a nationwide survey RID E-9967-2010. American Journal of Hypertension. 18. 1 indexed citations
19.
Mannelli, Massimo. (2000). Telomerase Activity Is Significantly Enhanced in Malignant Adrenocortical Tumors in Comparison to Benign Adrenocortical Adenomas. The Journal of Clinical Endocrinology & Metabolism. 85(1). 468–470. 10 indexed citations
20.
Mannelli, Massimo, Stefania Gelmini, Giorgio Arnaldi, et al.. (2000). Telomerase Activity Is Significantly Enhanced in Malignant Adrenocortical Tumors in Comparison to Benign Adrenocortical Adenomas. The Journal of Clinical Endocrinology & Metabolism. 85(1). 468–470. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026